NEW YORK, Aug 16 – Canadian life science company MDS has agreed to develop and commercialize Signature BioScience's microwave spectroscopy instrumentation, the companies announced.

MDS will pay Signature Biosciences $10 million upfront and will provide additional milestone and royalty payments in exchange for exclusive license rights to commercialize the microwave spectroscopy instrumentation and peripherals. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.